关注
Sarah L Mason
Sarah L Mason
在 cam.ac.uk 的电子邮件经过验证
标题
引用次数
引用次数
年份
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
CH Williams-Gray, SL Mason, JR Evans, T Foltynie, C Brayne, ...
Journal of Neurology, Neurosurgery & Psychiatry 84 (11), 1258-1264, 2013
6792013
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
S Palfi, JM Gurruchaga, GS Ralph, H Lepetit, S Lavisse, PC Buttery, ...
The Lancet 383 (9923), 1138-1146, 2014
5112014
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion
JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ...
Neurology 78 (10), 690-695, 2012
4142012
Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease
RA Barker, J Barrett, SL Mason, A Björklund
The Lancet Neurology 12 (1), 84-91, 2013
4122013
Glucocerebrosidase mutations influence the natural history of Parkinson’s disease in a community-based incident cohort
SE Winder-Rhodes, JR Evans, M Ban, SL Mason, CH Williams-Gray, ...
Brain 136 (2), 392-399, 2013
3292013
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study
DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ...
The Lancet Neurology 16 (9), 701-711, 2017
2832017
The natural history of treated Parkinson's disease in an incident, community based cohort
JR Evans, SL Mason, CH Williams-Gray, T Foltynie, C Brayne, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (10), 1112-1118, 2011
2732011
Cerebrovascular and blood-brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology.
CF Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagacé M, Kuan WL, Saint-Pierre M ...
Annals of Neurology, 2015
2572015
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
G Liu, B Boot, JJ Locascio, IE Jansen, S WinderRhodes, S Eberly, ...
Annals of neurology 80 (5), 674-685, 2016
2522016
Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study
M Politis, N Pavese, YF Tai, L Kiferle, SL Mason, DJ Brooks, SJ Tabrizi, ...
Human brain mapping 32 (2), 258-270, 2011
2322011
Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study
JS Paulsen, JD Long, HJ Johnson, EH Aylward, CA Ross, JK Williams, ...
Frontiers in aging neuroscience 6, 78, 2014
2262014
The Cambridge behavioural inventory revised
HJ Wear, CJ Wedderburn, E Mioshi, CH Williams-Gray, SL Mason, ...
Dementia & neuropsychologia 2, 102-107, 2008
2252008
The utility of the Cambridge Behavioural Inventory in neurodegenerative disease
C Wedderburn, H Wear, J Brown, SJ Mason, RA Barker, J Hodges, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (5), 500-503, 2008
2012008
Healthrelated quality of life in Huntington's disease: which factors matter most?
AK Ho, AS Gilbert, SL Mason, AO Goodman, RA Barker
Movement Disorders 24 (4), 574-578, 2009
1962009
Motor abnormalities in premanifest persons with Huntington's disease: the PREDICTHD study
KM Biglan, CA Ross, DR Langbehn, EH Aylward, JC Stout, S Queller, ...
Movement Disorders 24 (12), 1763-1772, 2009
1812009
A randomized, doubleblind, placebocontrolled trial of pridopidine in Huntington's disease
Huntington Study Group HART Investigators
Movement Disorders 28 (10), 1407-1415, 2013
1502013
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
G Liu, JJ Locascio, JC Corvol, B Boot, Z Liao, K Page, D Franco, K Burke, ...
The Lancet Neurology 16 (8), 620-629, 2017
1472017
Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington’s disease
I Reuter, YF Tai, N Pavese, KR Chaudhuri, S Mason, CE Polkey, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 948-951, 2008
1392008
Alteration of blood–brain barrier integrity by retroviral infection
PV Afonso, S Ozden, MC Cumont, D Seilhean, L Cartier, P Rezaie, ...
PLoS pathogens 4 (11), e1000205, 2008
1262008
Long-term follow-up of a phase I/II study of ProSavin, a lentiviral vector gene therapy for Parkinson's disease
S Palfi, JM Gurruchaga, H Lepetit, K Howard, GS Ralph, S Mason, ...
Human Gene Therapy Clinical Development 29 (3), 148-155, 2018
1212018
系统目前无法执行此操作,请稍后再试。
文章 1–20